Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHARM: Contraceptive Hormone and Reward Measurement
NCT05058872Phase 4Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Oct 2021
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of avatrombopag, ethinyl estradiol in contraception, sponsored by University of Colorado Denver. Started Oct 2021; status: recruiting.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05058872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05058872.